BioDrugs

BioDrugs

1173-8804

1179-190X

Therapeutic Area

Biotechnology, Infectious Diseases/ Infectology, Pharmacology, Research

Academics, Advanced Practice Nurses, Advanced Practice Trauma Nurses, Allergists, Allied Health Professionals, Andrologists, Anesthesiologists, Biologists, Cardiologists, Cardiovascular Surgeons, Caregivers, Colorectal Surgeons, Critical Care Nurses, Critical Care Physicians, Dermatologists, Electrophysiologists, Endocrinologists, Family Practice Physicians, Gastroenterologists, General Practitioners, Geriatricians, Gerontologists, Gynecologists, Hematologists, Hepatologists, Home Care Nurses, Hospice Nurses, Immunologists, Infectious Disease Specialists, Internists, Midwives, Neonatologists, Nephrologists, Neurologists, Neuroscientists, Nurse Oncologists, Nurse Practitioners, Nurse Practitioners/Physician Assistants, Nurses, Obstetricians, Oncologists, Ophthalmologists, Otolaryngologists/ENT Specialists, Pain Specialists, Patients, Pediatricians, Perinatologists, Pharmacists, Physiatrists, Physicians, Physicists, Primary Care Physicians, Pulmonologists, Radiation Oncologists, Residents, Rheumatologists, Scientists, Urologists

BioDrugs covers the development and therapeutic application of biotechnology-based pharmaceuticals and diagnostic products for the treatment of human disease. The Journal includes: - Definitive reviews on topics relating to the development and use of biotechnology in healthcare and the management of disease. - Systematic reviews that collate empirical evidence to answer a specific research question, using explicit, systematic methods as outlined by the PRISMA statement. - Original research articles on the clinical development and therapeutic application of biotechnology-based pharmaceuticals and diagnostic products. - Leading/Current Opinion articles providing an overview of contentious or emerging issues and key regulatory and ethical issues. - Adis Drug Evaluations reviewing the properties and place in therapy of biotechnology-based drugs. - Adis Biosimilar Briefs summarizing key characteristics and clinical use of biosimilar drugs. BioDrugs offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand the scientific content and overall implications of the article. The journal also provides the option to include various types of digital features including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations. All additional features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager®, supported by a database of international experts. This database is shared with other Adis journals. "An essential resource for R&D professionals and clinicians with an interest in biologic therapies. BioDrugs covers the development and therapeutic application of biotechnology-based pharmaceuticals and diagnostic products for the treatment of human disease. The journal Also offers the ability to create digital features as well as host them.

No associations affiliated with this journal

Adis, part of Springer Nature

Impact Factor JCR Categories/Rank Electronic Circulation Submission to Acceptance Acceptance to Online Publication Acceptance to Print Publication Rejection Rate Frequency Journal Contact Author Submission Guidelines